Three-year efficacy of the urethral bulking agent BULKAMID®™ for treatment of stress or mixed urinary incontinence: A bi-center retrospective study

Key Points

• The urethral bulking agent BULKAMID® shows improved efficacy for both stress and mixed urinary incontinence over three years.
• After treatment, 75% of participants reported improvement in urinary incontinence symptoms within one year.
• This bi-center retrospective study evaluated outcomes across multiple patient records, enhancing data validity.
• Findings suggest BULKAMID® may provide a lasting solution, but further research is needed to confirm long-term effects.